RSDFX
Price
$40.40
Change
+$0.13 (+0.32%)
Updated
Jul 25 closing price
Net Assets
2.15B
VIVIX
Price
$70.44
Change
+$0.29 (+0.41%)
Updated
Jul 25 closing price
Net Assets
195.18B
Interact to see
Advertisement

RSDFX vs VIVIX

Header iconRSDFX vs VIVIX Comparison
Open Charts RSDFX vs VIVIXBanner chart's image
Columbia Dividend Opportunity Inst2
Price$40.40
Change+$0.13 (+0.32%)
VolumeN/A
Net Assets2.15B
Vanguard Value Index I
Price$70.44
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets195.18B
RSDFX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RSDFX vs. VIVIX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSDFX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 195B vs. RSDFX (2.15B). RSDFX pays higher dividends than VIVIX: RSDFX (2.82) vs VIVIX (2.19). RSDFX was incepted earlier than VIVIX: RSDFX (17 years) vs VIVIX (27 years). RSDFX (0.79) is less costly to investors than VIVIX (0.04). RSDFX is a more actively managed with annual turnover of: 33.00 vs. VIVIX (9.00). RSDFX has a lower initial minimum investment than VIVIX: RSDFX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 9.75 vs. RSDFX (8.02). VIVIX return over 5 years is better than : 74.87 vs. RSDFX (46.90).
RSDFXVIVIXRSDFX / VIVIX
Total Expense Ratio0.790.041,975%
Annual Report Gross Expense Ratio0.790.041,975%
Fund Existence17 years27 years-
Gain YTD8.1856.730122%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.15B195B1%
Annual Yield % from dividends2.822.19129%
Returns for 1 year8.029.7582%
Returns for 3 years23.0834.3267%
Returns for 5 years46.9074.8763%
Returns for 10 years37.10116.2632%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLAY3.740.06
+1.63%
Relay Therapeutics
INCR1.550.01
+0.65%
Intercure Ltd
EXPD116.70-0.14
-0.12%
Expeditors International of Washington
XIFR9.52-0.07
-0.73%
XPLR Infrastructure LP
NLSP1.98-0.18
-8.33%
Nls Pharmaceutics Ltd